Issuu on Google+

ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email!

Japan Pharma Company Outlook to 2016 Published on November 2011

Report Summary Introduction This analysis examines the outlook for companies in Datamonitor's Japan Pharma peer set. The report encompasses insight into key strategic themes across the group of companies and identifies sales trends using 6-year prescription pharmaceutical sales forecasts for all the companies covered. Features and benefits * Gain insight into Japan Pharma companies strategic outlook across the next 6 years * Analyze sales forecasts by company, therapy area, lifecycle stage, and molecule type. Highlights Strategic insight into the prospects for Japan Pharma companies over the next six years. Picking out key trends across the companies and comparing performance using a variety of cuts of forecast sales. Your key questions answered * Benchmark companies outlook against key rivals across Datamonitor's Japan Pharma peer set * Assess how M&A has played an intgeral role in driving historical growth of the Japanese peer set, and how M&A will remain strategically important

Table of Content Executive Summary Key findings Overview of the Japan Pharma peer set Japan Pharma prescription sales performance, 2004'16 The Japan Pharma company outlook to 2016 INTRODUCTION Data sourcing [Missing title] Further reading STRATEGIC INSIGHT M&A activity remains high as conditions favor deal-making for Japanese firms Rigid debt-free structure facilitates transactions Exchange rate effect Impact on sales

Japan Pharma Company Outlook to 2016 (From Issuu)

Page 1/4


ReportLinker

Find Industry reports, Company profiles and Market Statistics

>> Get this Report Now by email! Major domestic forces at play across the Japan Pharma landscape THE JAPAN PHARMA OUTLOOK TO 2016 Key findings Overview of the Japan Pharma peer set Japan Pharma prescription sales performance, 2004'16 Japan Pharma landscape, 2010'16 Japan Pharma company analysis Japan Pharma launch/core/expiry analysis Japan Pharma therapy area analysis Japan Pharma molecule type analysis APPENDIX References Datamonitor reports Exchange rates

Japan Pharma Company Outlook to 2016 (From Issuu)

Page 2/4


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to: ƒ ƒ

Europe, Middle East and Africa : + 33 4 37 37 15 56 Asia, Oceania and America : + 1 (805) 617 17 93

If you have any questions please visit http://www.reportlinker.com/notify/contact

Order Information Please verify that the product information is correct and select the format(s) you require. Japan Pharma Company Outlook to 2016

Product Formats Please select the product formats and the quantity you require. 1 User License--USD 3 800.00

Quantity: _____

Corporate License--USD 9 500.00

Quantity: _____

Contact Information Please enter all the information below in BLOCK CAPITALS

Title:

Mr

Mrs

Dr

Miss

Ms

Prof

First Name:

_____________________________ Last Name: __________________________________

Email Address:

__________________________________________________________________________

Job Title:

__________________________________________________________________________

Organization:

__________________________________________________________________________

Address:

__________________________________________________________________________

City:

__________________________________________________________________________

Postal / Zip Code:

__________________________________________________________________________

Country:

__________________________________________________________________________

Phone Number:

__________________________________________________________________________

Fax Number:

__________________________________________________________________________

Japan Pharma Company Outlook to 2016 (From Issuu)

Page 3/4


Find Industry reports, Company profiles and Market Statistics

ReportLinker

>> Get this Report Now by email! Payment Information Please indicate the payment method, you would like to use by selecting the appropriate box.

Payment by credit card

Card Number: ______________________________________________

Expiry Date

__________ / _________

CVV Number _____________________

Card Type (ex: Visa, Amex…) _________________________________

Payment by wire transfer

Crédit Mutuel RIB : 10278 07314 00020257701 89 BIC : CMCIFR2A IBAN : FR76 1027 8073 1400 0202 5770 189

Payment by check

UBIQUICK SAS 16 rue Grenette – 69002 LYON, FRANCE

Customer signature:

 

Please note that by ordering from Reportlinker you are agreeing to our Terms and Conditions at http://www.reportlinker.com/index/terms

Please fax this form to: Europe, Middle East and Africa : + 33 4 37 37 15 56

ƒ ƒ

Japan Pharma Company Outlook to 2016 (From Issuu)

Asia, Oceania and America : + 1 (805) 617 17 93

Page 4/4


Japan Pharma Company Outlook to 2016